We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). Show more
http://www.fool.com/investing/general/2015/12/05/these-3-etfs-jumped-in-november.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/30/last-weeks-top-healthcare-etf.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/22/3-biotech-stocks-to-buy-in-december.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/11/01/the-top-3-biotech-etfs-on-the-market.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
http://www.fool.com/investing/general/2015/05/31/improve-your-diversification-strategy-with-these-3.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/high-growth/2015/05/09/a-stock-market-bubble-in-biotech-stocks.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/beginning/2015/04/19/how-to-invest-money-in-biotech.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/etf/2015/03/31/these-3-etfs-are-crushing-the-market-in-2015.aspx?source=eptadnlnk0000002
http://www.fool.com/investing/general/2015/03/23/3-biotech-stocks-to-buy-if-the-sector-crashes.aspx?source=eptadnlnk0000002
State Street Global Advisors (SSGA) announced today that the SPDR® S&P Biotech ETF (NYSE: XBI), received payment as an authorized claimant from a class action settlement related to Human...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.16 | -4.42694476961 | 93.97 | 95.515 | 88.63 | 10817146 | 91.93098698 | SP |
4 | -4.97 | -5.24372230428 | 94.78 | 100.24 | 88.63 | 8651746 | 95.92192657 | SP |
12 | -8.99 | -9.0991902834 | 98.8 | 105.47 | 88.63 | 8428806 | 97.0646874 | SP |
26 | 0.42 | 0.469851213782 | 89.39 | 105.47 | 88.63 | 7990275 | 97.39027269 | SP |
52 | 3.71 | 4.30894308943 | 86.1 | 105.47 | 81.14 | 9312033 | 93.83957635 | SP |
156 | -24.71 | -21.5770171149 | 114.52 | 119.21 | 61.78 | 10087569 | 85.57972586 | SP |
260 | -6.79 | -7.02898550725 | 96.6 | 174.79 | 61.78 | 8452280 | 94.56190052 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions